| abstract |
The present invention provides compounds, compositions, and compositions for testing, diagnosing and treating traits, diseases and conditions that respond to modulation of TSLP gene expression and / or activity and / or modulate the TSLP gene expression pathway, and Regarding the method. Specifically, the present invention is capable of mediating or mediating RNA interference (RNAi) on TSLP gene expression, such as double stranded nucleic acid molecules, eg, small interfering nucleic acids (siNA), small interfering RNA (siRNA), two It relates to small nucleic acid molecules such as single-stranded RNA (dsRNA), microRNA (miRNA), and small hairpin RNA (shRNA) molecules. |